Pesquisa de mutações no gene inIA de Listeria monocytogenes by Silva, Isabel Margarida Carvalho Flórido Ferreira da
    
Universidade de Aveiro 
2012 
Departamento de Biologia 
Isabel Margarida 
Carvalho Flórido 
Ferreira da Silva 
 
PESQUISA DE MUTAÇÕES NO GENE inlA DE 
Listeria monocytogenes 
 
 
   
  
2 
 
 
Universidade de Aveiro 
2012  
Departamento de Biologia 
 
Isabel Margarida 
Carvalho Flórido 
Ferreira da Silva 
 
 
SEARCH FOR MUTATIONS ON GENE inlA OF 
Listeria monocytogenes  
 Dissertação apresentada à Universidade de Aveiro para cumprimento dos 
requisitos necessários à obtenção do grau de Mestre em Biologia Aplicada, 
ramo de Microbiologia Clínica e Ambiental, realizada sob a orientação científica 
do Doutor António Correia, Professor Catedrático do Departamento de Biologia 
da Universidade de Aveiro, Doutora Paula Teixeira, Professora Auxiliar da 
Escola Superior de Biotecnologia da Universidade Católica Portuguesa e 
Doutora Vânia Ferreira, aluna de Pós-doutoramento da Escola Superior de 
Biotecnologia da Universidade Católica Portuguesa.  
  Apoio financeiro da FCT no âmbito do 
projecto PEst-OE/EQB/LA0016/2011 
 
 
 
  
3 
 
  
  
 
 
 
Dedico este trabalho à minha família e amigos.   
 
 
 
  
4 
 
  
 
 
 
 
 
 
o júri   
 
presidente Prof. Doutor João António de Almeida Serôdio 
professor auxiliar do Departamento de Biologia da Universidade de Aveiro 
  
  
 Doutor Artur Jorge da Costa Peixoto Alves 
Investigador Auxiliar, Centro de Estudos do Ambiente e do Mar, Universidade de Aveiro 
 
   
 Prof. Doutora Paula Cristina Maia Teixeira 
professora auxiliar da Universidade Católica Portuguesa, Escola Superior de Biotecnologia 
 
  
 Prof. Doutor António Carlos Matias Correia 
professor catedrático do Departamento de Biologia da Universidade de Aveiro 
 
  
  
 
  
  
 
  
 
 
 
  
5 
 
  
  
 
agradecimentos 
 
Este trabalho não teria sido possível sem a cooperação da Escola Superior de 
Biotecnologia, Centro Regional do Porto da Universidade Católica Portuguesa. 
Agradeço em especial ao Centro de Biotecnologia e Química Fina (CBQF) e 
ao Centro de Investigação e Apoio Tecnológico (Cinate) de Microbiologia.  
Agradeço também ao grupo de Microbiologia Molecular do Instituto de Biologia 
Molecular e Celular (IBMC), liderado pelo Doutor Didier Cabanes, por todo o 
apoio prestado na cultura celular, em especial à Teresa Malheiro.  
Não posso deixar de agradecer à Universidade de Aveiro pelos 6 anos de 
formação superior que me proporcionou.  
 
Agradeço à Professora Paula Teixeira por ter aceite ser minha orientadora 
neste trabalho e agradeço em especial à Vânia Ferreira por tudo o que me 
ensinou ao longo deste ano e pela enorme ajuda que me prestou.  
 
Ao Rui Magalhães, Luísa, Isabel, Patrícia e Patrícia Guerreiro um enorme 
obrigado por toda a paciência e disponibilidade que tiveram em me ajudar. 
 
Aos meus colegas de laboratório Lúcia, Ângela, Ricardo, Ana Carvalheira, Ana 
Castro, Alexandra e Alexandra Pais agradeço o bom ambiente de trabalho, 
todos os momentos divertidos e agradeço em especial a forma como me 
receberam no laboratório. 
 
Reconheço a paciência e apoio indispensáveis da Rosa, Catarina, Beta, 
Mauro, Rafael e Igor durante este último ano.  
 
Agradeço em especial o apoio incondicional dos meus pais António Jorge e 
Isabel, do meu irmão Rui Jorge e do meu tio Zé durante toda a minha 
formação.  
 
 
 
 
 
 
  
6 
 
  
 
 
 
 
 
 
 
 
 
 
  
palavras-chave 
 
Gene internalina A, Listeria monocytogenes, ensaio de invasão em células 
Caco-2,  codões stop prematuros.  
 
resumo 
 
 
Listeria monocytogenes é uma bactéria patogénica de origem alimentar capaz 
de causar casos esporádicos e surtos de listeriose, uma doença invasiva 
severa. A proteína internalina A (InlA), codificada pelo gene inlA, tem um papel 
fundamental no processo de infeção, sendo necessária e suficiente para que L. 
monocytogenes ultrapasse a barreira intestinal e estabeleça uma infeção 
sistémica. Estudos sobre inlA de L. monocytogenes mostram que mutações 
que levam a codões stop prematuros ocorrem naturalmente e estão 
associadas a isolados com virulência atenuada. Foi sequenciado o gene inlA 
de onze isolados alimentares e onze isolados clínicos de L. monocytogenes 
recolhidos em Portugal com o objetivo de procurar mutações que levam ao 
aparecimento de codões stop prematuros, levando assim à produção de InlA 
truncada. Também foram testadas as eficiências de invasão de L. 
monocytogenes em linhas celulares Caco-2. Foram encontradas três tipos de 
mutações já descritas (6, 11 e 12), codificando uma proteína truncada com 
492, 576 e 685 aminoácidos. Os codões stop prematuros foram identificados 
em quatro isolados alimentares e num isolado clínico. Os resultados obtidos 
indicam que os isolados com codão stop prematuro no gene inlA revelam uma 
eficiência de invasão atenuada em células Caco-2.  
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abstract 
 
Listeria monocytogenes is a food-borne pathogen capable of causing 
listeriosis, a severe invasive disease and responsible for some outbreaks that 
occur occasionally. Internalin A protein (InlA) encoded by inlA gene has a key 
role in the infection mechanism, being necessary for L. monocytogenes to 
cross the intestinal barrier and to establish a systemic infection. Studies on inlA 
in L. monocytogenes have shown that mutations leading to premature stop 
codons (PMSC) occur naturally and are associated with attenuated virulence of 
this bacterium. inlA from eleven food and eleven clinical isolates of L. 
monocytogenes from Portugal, were sequenced to find mutations carrying 
PMSC leading to production of a truncated and secreted InlA. The invasion 
efficiencies of these strains of L. monocytogenes of the Caco-2 cell line were 
also tested. It was found three mutation types, previously described (6, 11 and 
12), leading to a predict truncated InlA of 492, 576 and 685 amino acids. The 
PMSCs were detected in four food and in one clinical isolates. The results 
show a reduced invasiveness, in Caco-2 cell line, of isolates with PMSCs in 
inlA. 
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1 Introduction 
 
1.1 Listeria monocytogenes 
 
 Listeria monocytogenes is a food-borne pathogen belonging to genus Listeria, 
motile, nonspore forming and non-encapsulated Gram positive bacteria, with low G+C 
DNA content as in other genera such as Staphylococcus, Streptococcus, Lactobacillus 
and Bronchothrix of the sub-branch Clostridium [2]. The Listeria genus comprises 
seven other species, namely: L. seeligeri, L. innocua, L. welshimeri, L. grayi [65], L. 
marthii [21], L. rocourtii [31] and L. ivanovii [65]. 
 Listeria monocytogenes, was first discribed in 1926, at Cambridge, England, as 
the etiological agent of a septicemic disease affecting rabbits and guinea pigs 
characterized by peripheral monocytosis [1], by E.G.D Murray, R. A. Webb and M. B. 
R. Swann (1926)  who named it Bacterium monocytogenes. Only in 1939 Pirie gave it 
the present name, Listeria monocytogenes, that was recognized by the International 
Committee on Systematic Bacteriology.  In 1929, L. monocytogenes  was isolated from 
infected humans by Nyfeldt, in Denmark [22];  the first L. monocytogenes human 
outbreak occurred in 1983 in Canada and the considerable clinical and microbiological 
interest in L. monocytogenes began after that [14, 22].  
 While L. monocytogenes is considered a major intracellular bacterial food 
pathogen, capable of causing serious disease, it is also well adapted to survive in soil 
and decaying vegetation as a saprophyte [23]. This bacterium grows between 0 and 45 
ºC, with an optimum temperature range between 30 and 37 ºC; in a wide pH range, 4 
to 9.6, and tolerates high salt concentrations, up to 10%  [13]. Thus it can be found in 
several environments such as soil, water, food (eg. vegetables, fermented sausages, 
seafood) and as an animal  pathogen [45], being a ubiquitous microorganism.  
 To distinguish L. monocytogenes from other species of Listeria spp. some 
biochemical tests can be performed, e.g using the comercial kit API based on the 
fermentation of sugars and enzymes activity and by combinations of the following 
tests: hemolysis, acid production from D-xylose, L-rhamnose, alpha methyl-D-
mannoside, and mannitol [55]. 
 Listeria spp. are catalase positive, and indole and oxidase negative, can 
hydrolyse aesculin but not urea and they vary in their ability to haemolyse horse or 
sheep red blood cells. Listeria monocytogenes is β-haemolytic positive as are L. 
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ivanovii and L. seeligeri, but it can be distinguished from these two species because it 
ferments rhamnose and does not ferment xylose unlike L. ivanovii and L. seeligeri [36]. 
Growth in PALCAM Listeria Agar, a selective and differential agar medium, is another 
way for isolation and enumeration of Listeria spp. and to detect L. monocytogenes from 
food and clinical samples [11]. ALOA (Agar Listeria Ottaviani & Agosti) can also be 
used for isolation of Listeria spp. from food samples and for presumptive identification 
of L. monocytogenes [38]. Identification of the species can be performed by molecular 
methods based on genotype as, e.g., 16S rRNA nucleic acid amplification [2, 36].  
 Thirteen serotypes have been described for L. monocytogenes based on surface 
proteins as somatic (O) and flagellar (H) antigens, and its agglutination by specific 
antisera. Serotypes 4b, 1/2b, and 1/2a account for more than 95% of human listeriosis 
cases [30, 61].  Serotype 4b is overrepresented among clinical isolates relative to food 
isolates and is associated with more severe clinical presentation and higher mortality 
rates [61]. Strains of this serotype contribute significantly to sporadic listeriosis and are 
responsible for most listeriosis outbreaks, including three previously defined epidemic 
clones (ECs) responsible for multiple outbreaks worldwide [29, 30].   
 Molecular subtyping studies consistently showed that L. monocytogenes  isolates 
cluster into four divergent genetic lineages, represented on table 1, namely: lineages I, 
II, III and IV. Lineage I includes serotypes 1/2b, 3b, 3c, and 4b; lineage II includes 
serotypes 1/2a, 1/2c and 3a; lineage III includes at least three different lineages 
(lineage IIIA, IIIB and IIIC), which all contain serotype 4a, 4c, and atypical serotype 4b 
isolates. Several recent phylogenetic studies have demonstrated that isolates classified 
as subgroup IIIB represent a distinct fourth lineage of L. monocytogenes [36, 47, 52]. 
While Lineage I isolates are significantly overrepresented among human listeriosis 
cases (in particular serotype 4b strains) [24, 27], Lineage II isolates have a higher 
prevalence among environmental samples, foods, and animal listeriosis cases [41, 57], 
and are underrepresented among clinical isolates [27]. Lineage III is mainly associated 
with listeriosis in animals [36]. 
 The first method used for differentiating L. monocytogenes was serotyping; today 
other methods have been used, such as ribotyping, pulsed-field gel electrophoresis 
(PFGE) and multilocus sequence typing (MLST).   
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1.2 Listeriosis 
 
 Listeria monocytogenes can cause the serious infection, termed listeriosis. In 
developed countries, the globalization of the food industry and the increase in 
consumption of ready-to-eat, particularly chilled foods, has increased listeriosis 
outbreaks in the last 30 years [1]. 
  Listeria monocytogenes has the ability to induce its own entry into host cells, 
usually mammalian cells (human and animal), such as macrophages, epithelial cells 
and endothelial cells of the gastrointestinal tract [9, 14] after the ingestion of 
contaminated food. It has been estimated that food-borne infections of listeriosis result 
in 90% of hospitalization and 20 to 30% of mortality  of patients [8, 30, 69]. 
 The majority of cases are found in immunosupressed patients (e.g. people with 
cancer, HIV infection, diabetes mellitus, heart problems, alcoholic individuals with 
cirrhosis, renal failure with dialysis), the elderly and pregnant women, as well as 
neonates [1, 14, 37]. Listeria monocytogenes infection can result in bacterial 
meningitis, rhombencephalitis, sepsis, endocarditis, pneumonia, hepatitis, peritonitis, 
osteomyelitis and gastroenteritis, the most common feature, in adults. [1]. There are 
subclinical cases, described in the USA, Italy and Scandavia, of listeriosis with 
symptoms like mild influenza [3, 37].   
Table 1 Summary of L. monocytogenes lineages.  
Lineage Initial identification Serotypes 
Genetic 
characteristics 
Distribution 
I Piffaretti et al. [48] 
1/2b, 3b, 
3c, 4b 
Lowest diversity 
among the lineages; 
lowest levels of 
recombination among 
the lineages. 
Commonly isolated 
from various 
sources; over-
represented among 
human isolates. 
II Piffaretti et al. [48]  
1/2a, 1/2c, 
3a 
Most diverse, highest 
recombination levels. 
Commonly isolated 
from various 
sources; over-
represented among 
food-related as well 
as natural 
environments. 
III Rasmussen et al. [51] 4a, 4b, 4c 
Very diverse; 
recombination levels 
between those for 
lineage I and lineage 
II. 
Most isolates 
obtained from 
ruminants. 
IV 
First reported as IIIb 
by Roberts et al. [53] 
First reported as IV 
by Ward et al. [66] 
4a, 4b, 4c 
Few isolates 
analyzed to date. 
Most isolates 
obtained from 
ruminants. 
Adapted from Orsi et al. [21] 
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 Listeriosis during pregnancy can cause amnionitis, preterm labor, spontaneous 
abortion, stillbirth or early-onset infection of the neonate. The early-onset results from 
intrauterine infection and it presentation is most often sepsis and sometimes respiratory 
distress [59]. The late-onset, 7-20 days after childbirth, is very similar to neonatal 
meningitis resulting in ≈ 10% of mortality [1].  
 Listeriosis can be treated with bacteriostatic concentrations of ampicillin or 
vancomycin combined with an aminoglycoside (normally gentamycin) or trimethoprim-
sulfamethoxazole with rifampicin during three weeks. Usually, L. monocytogenes is 
resistant to cephalosporins [1]. 
 
 
 
  
 Figure 1 demonstrates the saprophytic and infectious cycles of L. 
monocytogenes and its ability to infect organs such as brain, liver, placenta and 
bloodstream [18, 44]. The infection by L. monocytogenes mainly occurs by the 
ingestion of contaminated food [8] and, although the acid pH of stomach, some L. 
monocytogenes passthrough to the small intestine, the first site where invasion occurs 
[37]. From there L. monocytogenes can spread from cell to cell without being in the 
extracellular environment, thus escaping from the human T-cell immune system, and 
invading other tissues and organs [18]. Listeria monocytogenes cell infection can be 
divided in four main steps (Figure 2) associated with different virulence factors [9, 44]. 
Figure 1 Saprophytic and infectious cycles of L. monocytogenes. In Orndorff et al.  [44]. 
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 To invade, L. monocytogenes needs to adhere to the surface of host cells 
through the family of internalin surface proteins (InlA and InlB mainly) that are 
reconized by a specific host surface protein. Host cells recognize InlA through E-
cadherin [9] and InlB through the hepatocyte growth factor (HGF) receptor Met [4]. 
Once inside the host cell, L. monocytogenes has to survive in a phagocytic vacuole 
and for that it uses two more virulence factors: listeriolysin O (LLO) and phospholipase 
C (PLC). The listeriolysin O is a cytolysin that forms a pore; phospholipase C (PI and 
PC) are responsible, at the same time, for lysing the vacuole formed around L. 
monocytogenes. The last step involved in the L. monocytogenes infection process, is 
its transfer into neighbouring cells that occurs in the same way of its entrance into the 
host cell, ie, with LLO and PLC action to lyse the second vacuole previously formed [9, 
44, 65].  
 
 
Figure 2  A: Listeria invasion process. 1 entry into host cell – zipper mechanism; 2 and 3 
survival in and lysis of phagocytic vacuole by acidification; 4 duplication in 1 hour; 5 motility 
based on actin filaments polymerization; 6 cell-to-cell spread by double membrane vacuole 
formation; 7 and 8 survival and lysis of double membrane phagosomes. Adapted from Vázquez-
Boland et al. [65]. B: Virulence factors required for Listeria invasion. Adapted from Cossart and 
Lecuit [10].   
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1.3  Internalin A  
 
 Internalin A protein (InlA) has been shown to be the most important factor for 
host-cell invasion because it acts as both adhesins and integrins and Lecuit et al. [35].  
suggested that InlA is the key virulence factor in oral infections. Although InlA and InlB 
have been recognized as the most important L. monocytogenes cell-surface proteins 
responsible for promoting host cell invasion, 24 more internalin proteins have been 
described [5, 33].  
 InlB belongs to the second group of surface proteins in Gram-positive bacteria 
that bind to the cell wall by non-covalent interactions. This protein has a signal peptide, 
at leucine-rich repeat (LRRs) domains and a C-terminal domain with three highly 
conserved tandem repeats of 80 amino acids, and the GW modules (Gly-Trp), 
necessary to anchor InlB to the bacterial surface [4, 6]. 
 InlA protein is the first virulence factor identified in L. monocytogenes allowing the 
entry of the bacterium into non-phagocytic host cells, this process is called 
internalization. The interaction with the host cell occurs by the linkage of InlA to the 
human isoform of E-cadherin transmembranar protein, allowing L. monocytogenes to 
cross the intestinal and feto-placental barriers [32, 39, 46, 70]. E-cadherin is a cell 
adhesion protein of mammalian cells, necessary for the formation of cell-cell junctions 
of polarized epithelial cells and is connected to cytoskeletal proteins. The recognition of 
InlA occurs through Pro residue on the position 16 in a hydrophobic and uncharged 
loop of E-cadherin, suggesting that InlA-E-cadherin interaction is hydrophobic [4, 5, 58, 
62].  
 InlA is an 800 aa surface protein (Figure 3) belonging to the LPXTG proteins [46] 
with a signal peptide in the amino-terminal, followed by a LRR domain (a tandem 
repeat of 20-22 aminoacids with a role in protein interactions and activation); the next 
region is an inter-repeat domain (IR) crucial for the interaction with E-cadherin and a -
repeat region. The last region, at the carboxyl-terminal, is the sorting signal which has 
the LPXTG motif (X is any aminoacid), a hydrophobic region with 20 aminoacids and a 
tail of positive residues. The carboxyl-region is fundamental for covalent attachment of 
InlA to the peptidoglycan of the Gram-positive cell wall, by the action of sortase A 
(SrtA) [4, 6, 19, 28, 33, 70].  
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 Interesting data from Gaillard et al. [19] shows that InlA confers invasiveness to 
non-invasive Gram-positive bacteria, as, e.g., L. innocua  by the introduction of a 
plasmid pGM4 with inlA into noninvasive L. innocua [19]. 
 Jonquières et al. [28] compared the invasiveness of strain LO28 and strain 
EDGe, in Caco-2 cells, and concluded that strain LO28 presented a low internalization 
efficiency and the Western blotting analysis demonstrated a protein with lower 
molecular weight when compared with EDGe protein. These results indicated the 
ocurrence of frameshift mutations in inlA gene, resulting in premature stop codons 
(PMSC). Thus the expressed InlA protein is truncated or not secreted, if the PMSC is 
located at 5´end of the gene [40], and L. monocytogenes therefore cannot be detected 
by E-cadherin of the host cells [5, 28]. Figure 4 presents examples of truncated InlA 
and the incapacity to be recognized by the host cell. The same study showed that this 
is not a rare event and later studies confirmed these observations, emphasizing the 
idea of InlA as a key virulence factor in L. monocytogenes [5, 28, 41]. The truncated 
form of InlA appears more in food strains, while in clinical strains the full-length InlA 
usually occurs [5, 26, 40, 41]. These data prove the fundamental role of InlA in the 
crossing of the intestinal barrier in humans.  
 
Figure 3 A: Schematic representation of InlA. Adapted from Lecuit et al. [33]. B: Uncomplexed 
InlA. Adapted from Schubert et al. [21] 
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 So far, 18 types of inlA mutations leading to PMSCs that result in a truncated 
form of InlA incapable of anchoring to the bacteria cell wall, have been described 
(Figure 5) [63, 64]. Mutations leading to PMSC in inlA were found in isolates collected 
in several countries e.g. USA [41, 46], Portugal [15, 16], France [26, 28, 42] and Japan 
[25]. Usually, inlA from L. monocytogenes isolates are sequenced and compared with 
the inlA gene from the EDGe strain that secretes a full-length InlA; this methodology 
allows the detection of PMSC. 
 
Figure 4 Interaction of InlA protein and E-cadherin and truncated forms of InlA in L. 
monocytogenes. InlA1: full-lengh internalin, capable of promoting entry of L. monocytogenes 
into host cells because it retains the carboxy-terminal motif for anchoring to the bacterial 
surface. InlA2, InlA3 and InlA4: variants of truncated internalins. In Jacquet et al. [26] 
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 The first frameshift mutation (an adenine deletion at 1637 position) leads to a 
nonsense codon (TAA) in the position 1729 that encodes for a 63 kDa protein instead 
of an 88 kDa protein, was described by Jonquières et al. [28]. Ten more studies, 
Figure 5 Representation of full-length InlA (A) and truncated InlA (B – O) with respective 
mutation type, described by several studies. N, N-terminal; S, signal sequence; LRR, leucine-
rich repeat; IR, intergenic repeat; MA, membrane anchor; C, C-terminal end. Numbers at the 
right end for lines B to N represent the aa position of each respective PMSC. In Van Stelten et 
al. [64]  
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between the year 1998 and 2010, have found 17 mutations leading to PMSCs, 
described in detail on Table 2. 
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PMSC 
mutation 
type
a 
Protein 
length 
(aa) 
Mutant 
allelic 
type 
Wild allelic 
type 
Nucleotide 
position of 
PMSC 
mutation 
Isolate type Serotype 
Country 
origin 
Reference 
1 606 A T 1818 
Clinical 
Food 
Environmental 
1/2b USA 
Nightingale et al. [41] 
Van Stelten and Nightingale [63] 
Van Stelten et al. [64] 
2 656 T C 1966 
Clinical 
Food 
Environmental 
1/2b USA 
Nightingale et al. [41] 
Van Stelten and Nightingale [63] 
Van Stelten et al. [64] 
3 700 G C 2100 
Clinical 
Food 
Environmental 
1/2a USA 
Nightingale et al. [41] 
Van Stelten and Nightingale [63]  
Van Stelten et al. [64] 
4 9 C A 
6 -12 Adenine 
residues 
Clinical 
Food 
Environmental 
1/2c or 3a 
Portugal  
USA 
Orsi et al. [46] 
Felício et al. [15] 
 Van Stelten and Nightingale [63] 
5 189 T C 565 
Clinical 
Food 
b 
USA 
Van Stelten and Nightingale [63] 
Van Stelten et al. [64] 
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492 T C 1474 
Clinical 
Food 
 
b 
France 
Portugal 
USA 
Olier et al. [43] 
Felício et al. [15] 
Van Stelten and Nightingale [63] 
Van Stelten et al. [64] 
Ragon et al. [49] 
7 562 T C 1684 
b b 
USA Van Stelten and Nightingale [63] 
8 460 - G 
1539 
deletion 
Food 1/2a France Rousseaux et al. [56] 
Table 2 PMSC mutations described since 1998 to 2010 in inlA. 
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9 519 - G 
1539 
deletion 
Food 1/2c France Rousseaux et al. [56] 
10 677 T - 
1901 
insertion 
Food 1/2a France Rousseaux et al. [56] 
11 685 A G 2054 Food 1/2c France 
Rousseuax et al. [56] 
Ragon et al. [49] 
12 576 - A 1637 
Clinical 
Food 
1/2c or 3c 
France 
Portugal 
USA 
Jonquières et al. [28] 
Rangon et al. [49] 
Felício et al. [15] 
Van Stelten and Nightingale [63] 
Van Stelten et al. [64] 
13 527 T A 1578 Food 1/2a Japan Handa-Miya et al. [25] 
14 539 T C 1615 
b b
   France Ragon et al. [49] 
15 77 T C b Food 1/2a USA Ward et al. [67] 
16 170 T G b Food 1/2b USA Ward et al. [67] 
17 253 A T b Food 1/2b USA Ward et al. [67] 
18 404 - T 
1165 
(deletion) 
Clinical 4b USA Ward et al. [67] 
a
 According to Van Stelten et al. [64]; 
b
 Information not available 
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 Van Stelten et al. [64] hypothesised that isolates with mutations type 1, 3 and 4 
have been accumulated at the population level, since these mutations represent 90% 
of the inlA PMSC mutations observed in USA isolates (mostly mutation type 3). 
Futhermore, inlA mutations leading to PMSCs seem to be a common event in food 
isolates and for the most part, the described mutation types are exclusively in isolates 
from each respective country where those mutations were originally described [64]. 
 Listeria monocytogenes isolates with PMSC mutation leading to a truncated form 
of InlA, usually have reduced invasion efficiency in the human colorectal 
adenocarcinoma epithelial cell line - Caco-2 cells. So the invasion assays with Caco-2 
are a strong tool to predict the presence of inlA mutations [40, 63, 66]. Gaillard et al. 
[20] used the Caco-2 cell line to investigate the ability of L. monocytogenes to enter 
into intestinal epithelial cells, through the specific interaction with E-cadherin [35, 60], 
as it is the only cell line similar to differentiated enterocytes [20] and L. monocytogenes 
entry depends on the InlA pathway [7]. In several studies Caco-2 invasion assays have 
been selected to demonstrate reduced invasion efficiency of L. monocytogenes 
carrying a PMSC mutation and to correlate this data with reduced human virulence of 
some strains of L. monocytogenes [15, 40-42, 63]. Nightingale et al. [40] demonstrated 
the interesting result that human exposure to attenuated virulence of food isolates 
carrying PMSC mutations in inlA,  may confer protection against virulent isolates (with 
full length InlA), thus starting a new approach to listeriosis prevention [40, 64]. 
 
 
1.4 Aim of thesis  
 
 The surface protein InlA, encoded by inlA, has been associated with the invasion 
of human intestinal epithelial cells by L. monocytogenes that express certain isoforms 
of E-cadherin, making the interaction between InlA and E-cadherin a critical first step 
for crossing the intestinal barrier during the initial stages of a L. monocytogenes 
infection. Isolates harboring PMSC mutation in inlA, resulting in truncated forms of InlA,  
present virulence-attenuated phenotypes and impaired invasiveness of human 
intestinal epithelial cells in animal models. Increasing evidence suggests that inlA 
PMSC mutations are frequent in strains isolated from foods, but rare among clinical 
isolates. Limited information is available on the prevalence of such mutations among 
isolates collected from Portuguese samples. Such information would be critically 
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needed for adequate assessments of the foodborne illness burden associated with L. 
monocytogenes strains circulating in the country. 
 The aim of this study was to evaluate the prevalence of PMSCs in inlA of L. 
monocytogenes strains collected from food and clinical samples in Portugal. 
Characterization of the strains was accomplished (i) phenotypically by Caco-2 invasion 
efficiency assays and (ii) genetically by inlA sequencing.  
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2  Materials and methods 
2.1 Listeria monocytogenes isolates 
 
 For this study a set of 22 bacterial isolates from food and clinical origin collected  
in Portugal between 2001 and 2011 were selected from the L. monocytogenes 
collection of Escola Superior de Biotecnologia-Universidade Católica Portuguesa. 
Some isolates had previously been characterized by Pulsed Field Gel Electrophoresis 
(PFGE) and geno-serotyping by multiplex-PCR as previously described by Doumith et 
al. [12]. Food and clinical isolates previously studied by Ramalheira et al. [50], for their 
capacity to survive through simulated gastrointestinal tract conditions, representing 
several PFGE types and serotypes, were selected to represent the diversity of L. 
monocytogenes associated with different food sources and clinical cases. Furthermore,  
two clinical (2562 and 2666) and one food (2652) isolates related to the Portuguese 
outbreak of listeriosis that occurred in the Region of Lisboa and Vale do Tejo in 2010, 
were selected. Isolates FSL F8-146 and FSL F8-144 were used as positive and 
negative controls, respectivelly. Information on the selected strains of L. 
monocytogenes are described on Table 3.  
  
aL. 
monocytogenes 
isolate 
Origin Serogroup 
aPFGE 
pulsotype 
Date 
747 Food Cheese  1/2b 0040 2003 
842 Food Swab sample 1/2c 0208 2003 
854 Food Lettuce salad 4b ---- 2003 
903 Food Roast chicken 4b ---- 2004 
925/3 Food Goat cheese 1/2b 0016 2004 
930/1 Food Goat milk  1/2b ---- 2004 
994/1 Food Goat milk 1/2a 0005 2004 
1044 Food Meal  4b ---- 2004 
1216 Food Raw chicken 1/2b 0278 2004 
1305 Food 
Non-fermented 
sausage 
1/2c 0206 2005 
2652 Food Goat and cow 4b 0101 2011 
Table 3 L. monocytogenes strains characterization.  
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fresh cheese 
1001 Clinical Blood  4b 0019 2004 
1547 Clinical Blood  1/2b 0008 2001 
1761 Clinical CSF catheter 1/2b 0032 2005 
1891 Clinical CSF 1/2b 0048 2006 
2065 Clinical Blood  1/2b 0037 2007 
2074 Clinical Blood  4b 0072 2007 
2086 Clinical Blood 1/2a 0036 2007 
2092 Clinical Blood 4b 0065 2007 
2103 Clinical Blood 1/2a 0009 2007 
2562 Clinical Blood 4b 0101 2010 
2666 Clinical Blood 4b 0070 2010 
FSL F8-144 Control n/a 1/2a 356 2004 
FSL F8-146  Control n/a 1/2b 346 2004 
aCodes in L. monocytogenes collection of Escola Superior de Biotecnologia-
Universidade Católica Portuguesa. n/a – not applicable 
 
 
2.2 DNA extraction 
 
 For each isolate, one colony grown on Brain Heart Infusion (BHI) (Lab M Limited, 
Lancashire, UK) Agar No 1 Bacteriological (Lab M Limited, Lancashire, UK) (37 ºC, 
overnight) was cultured in BHI broth and incubated at 37 ºC, overnight. A 250 µL 
aliquot of bacterial cells was pelleted (10,000 g) for 10 min and re-suspended in 95 µL 
of 1x PCR buffer (Fermentas, Mundolsheim, France) and 4 µL of a 50 mg/mL lysozyme 
solution (Sigma, Steinheim, Germany). After incubation at room temperature (RT) for 
15 min, 1 µL of 20 mg/mL proteinase K (Eurobio GEXPRK01-B5, Scandinavia)  
solution was added and incubated at 58 ºC for 60 min. Enzymes were heat inactivated 
at 95 ºC, for 10 min, and the DNA stored at -20 ºC.  
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2.3 internalin A Sequencing 
 
 Listeria monocytogenes isolates were screened for the presence of PMSCs in 
inlA using the pairs of primers described in Table 4. inlA gene was amplified by PCR 
using four pairs of primers that cover the whole inlA ORF.  
 For each isolate, a 25 µL PCR reaction mixture was prepared containing: 1x 
KAPA HiFi Fidelity Buffer  containing 2.0 mM Mg2+ (KAPA Biosystems, Woburn, USA), 
0.3 mM of each deoxynucleotides triphosphate (Bioron, Ludwigshafen, Germany ), 0.3 
μM of each primer (Stabvida, Lisboa, Portugal) and 0.02 U/µL of KAPA HiFi DNA 
Polymerase (KAPA Biosystems), and 0.5 µL of DNA extract. 
 For the primers inlA proF/inlA proR, inlA F1/inlA S1R and inlA F2/inlA S2R the 
cycle used was: 3 min at 95 ºC; 30 cycles of 20 sec at 98 ºC, 15 sec at 62 ºC and 15 
sec at 72 ºC; and a final cycle of 5 min at 72 ºC. The primer inlA seqF/inlA R has the 
same cycle except the annealing temperature was 67 ºC. The PCR reaction was 
performed in DNA Engine Peltier Thermal Cycler Chromo 4 (Bio-Rad, Hercules, USA).  
 The electrophoresis was performed with 5 µL of PCR product and 3 µL of Sample 
Loading Buffer (Bioline, UK)  in a 1% SeaKem ® LE Agarose gel (Lonza, Rockland, 
USA) containing 1000x Midori Green Advanced DNA Stain (Nippon Genetics Europe 
GmbH, Düren, Germany), for 45 min at 95 V. Gels were photographed under UV 
transillumination (GelDoc 2000, Bio-Rad). 
 The PCR products were purified using the EzWay PCR Clean-Up Kit 
(Komabiotech, Seoul, Korea) and the DNA sequencing was performed by Macrogen 
Inc., Korea, using the same primers used for PCR of inlA amplification. The analysis of 
the sequences was done on Geneious 4.8.2 program and on Mega 5.05. 
 
Primer Sequence (5’ – 3’)
a
 
Amplicon 
size 
inlA proF 
inlA proR 
For: TTT TAA AAG GTG GAA TGA CA 
Rev: GAA GCG TTG TAA CTT GGT CTA 
500 bp 
inlA F1 
inlA S1R 
For: CAG GCA GCT ACA ATT ACA CA 
Rev: GGA CTG ATG TTA CTT ATT TGG T 
800 bp 
inlA F2 
inlA S2R 
For: AAG ATA TAG GCA CAT TGG CGA GTT 
Rev: CGT ACT GAA ATY CCA KTT AGT TCC 
800 bp 
inlA seq F 
inlA R 
For: GTG GAC GGC AAA GAA ACA AC 
Rev: ATA TAG TCC GAA AAC CAC ATC T 
900 bp 
a For, forward; Rev, reverse 
Table 4 Primers for inlA PCR and sequencing 
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2.4 Caco-2 cells invasion assays  
 
 Caco-2 (tumor-derived human colorectal epithelial cell line) cells invasion assays 
were performed to determine the invasion efficiency of L. monocytogenes as it requires 
InlA protein. A reduction in invasion efficiency could be explained by inlA mutations that 
code for a truncated protein [40].  
 The Caco-2 cells were grown in a T75 flask using Eagle´s minimal essential 
medium (EMEM) (Lonza, Verviers, Belgium) containing 20% fetal bovine serum (FBS) 
(Lonza), 1% sodium pyruvate (Lonza) and 1% non-essential aa (Lonza). For the 
invasion assays, 5.0x104 Caco-2 cells per well in 24-well plates were used, previously 
grown in EMEM with FBS, sodium pyruvate and non-essential aa, and were incubated 
for 48 h at 37 ºC with 7% (v/v) CO2 atmosphere.  
 Listeria monocytogenes strains were grown in BHI for 16 h at 37 ºC without 
shaking, and approximately 2x107 CFU/mL were inoculated into Caco-2 monolayers 
and allowed an infection time of 60 min at 37 ºC with 7% (v/v) CO2, in triplicate wells. 
The exact inoculum was determined by plating on BHI agar. Following the infection 
time, the medium was aspirated and gentamicin solution 20% (Lonza) was added and 
incubated for 90 min at 37 ºC with 7% (v/v) CO2, to kill remaining extracellular bacteria.  
After the gentamicin action, the medium was aspirated and cells washed with PBS. 
Post-infection, Caco-2 cells were lysed with 1 mL of Triton solution 0.2% (Sigma)  for 
10 min at room temperature and collected with vigorous pippeting. Intracellular L. 
monocytogenes cells were enumerated on BHI plates, which were subsequently 
incubated at 37 ºC for 24 h. Two control strains were included in each invasion assay; 
FSL F8-146 as a 100% invasion efficiency and FSL F8-144 as a 2% low invasion 
efficiency [16, 40]. 
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3 Results 
 
3.1 inlA sequencing of L. monocytogenes isolates 
 
 Sequencing analysis of inlA of the 22 L. monocytogenes isolates described in 
Table 5 shows that isolates 854, 903, 925/3, 930/1, 994/1, 1044, 1001, 1547, 1891, 
2065, 2074, 2086, 2092, 2103, 2562, 2652 and 2666 do not have mutations leading to 
a truncated form of InlA.  
 Listeria monocytogenes food isolate 842 shows a mutation type 12, leading to 
PMSC in the nucleotide 1729, with a deletion of an adenine (A) in the position 1637, 
the predicted InlA protein of this isolate has 577 aa. Isolate 1216 and 1761, food and 
clinical isolates respectively, show the same mutation type 6, leading to PMSCs in the 
nucleotide 1474 after a substitution of one citosine for one thymine (T) in the position 
1474, the predicted InlA protein has 492 aa. Only one clinical isolate (1761) shows a 
mutation in inlA leading to a truncated form of InlA. The food isolates 747 and 1305 
show a mutation type 11, leading to PMSCs in the nucleotide 2053, with a substitution 
of one guanine (G) for an adenine in the position 2054, the predicted protein has 685 
aa.  
 
L. monocytogenes 
isolate 
inlA type of 
mutation 
Mutant 
allelic 
type 
Wild allelic 
type 
Nucleotide 
position of 
PMSC 
mutation 
Length of 
predicted 
protein (aa) 
747 Mutation 11 A G 2054 685 
842 Mutation 12 n/a A 1729 576 
854 No mutation n/a n/a n/a 800 
903 No mutation n/a n/a n/a 800 
925/3 No mutation n/a n/a n/a 800 
930/1 No mutation n/a n/a n/a 800 
994/1 No mutation n/a n/a n/a 800 
1044 No mutation n/a n/a n/a 800 
Table 5 inlA mutations leading to PMSC found in L. monocytogenes isolates. 
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1216 Mutation 6 T C 1474 492 
1305 Mutation 11 A G 2054 685 
2652 No mutation n/a n/a n/a 800 
1001 No mutation n/a n/a n/a 800 
1547 No mutation n/a n/a n/a 800 
1761 Mutation 6 T C 1474 492 
1891 No mutation n/a n/a n/a 800 
2065 No mutation n/a n/a n/a 800 
2074 No mutation n/a n/a n/a 800 
2086 No mutation n/a n/a n/a 800 
2092 No mutation n/a n/a n/a 800 
2103 No mutation n/a n/a n/a 800 
2562 No mutation n/a n/a n/a 800 
2666 No mutation n/a n/a n/a 800 
FSL F8-144 Mutation 4 C A 12 9 
FSL F8-146 No mutation  n/a n/a n/a 800 
n/a – not applicable 
 
 
3.2 Caco-2 cells invasion capability of L. monocytogenes isolates 
 
 The 22 L. monocytogenes isolates were characterized for invasion efficiency in 
Caco-2 cells (figure 6). FSL F8-146 was used as a positive control, defined with 100% 
invasion efficiency [16].  
 Figure 6 shows that clinical isolates 1891, 2086, 2092, 2562, 2065, 2666 and 
2074 and food isolates 854, 2652 and 903 have high invasion efficiencies compared to 
the positive control (FSL F8-146). The food isolates 1216, 842, 1305, 1044, 994/1, 
925/3, 930/1 and 747 and the clinical isolates 1547, 1761, 2103 and 1001 demonstrate 
reduced invasion efficiency compared with the positive control. The average invasion 
efficiencies for these isolates ranged from 0.9 to 65.2%, relative to the positive control. 
The maximum efficiency value observed was 739.4%, for the isolate 2074.  
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 Invasion assays of isolates 1001, 1891, 2086, 903 and 2666 need to be repeated 
as high standart deviations were observed.  
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Figure 6. Caco-2 cell invasion efficiencies for 22 L. monocytogenes isolates. Values represent 
average invasion efficiencies (normalized to that of the control strain (FSL F8-146) for 2 - 3 
independent replicates; error bars indicates ranges. FSL F8-144 isolate was included as an 
invasion attenuated control.         Clinical isolates              Food isolates          Controls 
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4 Discussion 
 
 
 Twenty two Portuguese isolates of L. monocytogenes (food and clinical) were 
screend for the presence of PMSC mutations in inlA and also invasion assays were 
performed on Caco-2 cells to tentativelly relate the mutations with attenuated invasion 
phenotypes. An invasion efficiency of 100% was defined for the isolate FSL F8-146, 
based on results from Ferreira et al. [17] (positive control) as it does not show PMSC in 
inlA, encoding a predicted full-length InlA.  All the other invasion efficiencies are values 
normalized to that of the FSL F8-146. It is important to point out that invasion 
efficiencies above 100% may not represent high virulence of the isolates as 100% 
invasion efficiency for strain FSL F8-146 is only a reference value.  
 All the three mutation types found (6, 11 and 12) in five isolates were previously 
described. The remaining seventeen isolates tested did not show PMSC in inlA.  
 Isolates 1761 and 1216 presented the mutation type 6. This mutation was first 
described by Olier et al. [43] in France, in an isolate from a healthy pregnant carrier. 
Five more research groups from France [49], Portugal [15] and USA [63, 64] described 
this mutation in food and clinical isolates. In this study, the mutation type 6 was found 
in a 1/2b clinical isolate (1761), the only clinical isolate that shows a mutation in inlA 
leading to a truncated form of InlA,  and in a 1/2b food isolate (1216). Both isolates 
1761 and 1216, showed reduced invasion efficiency in Caco-2 cells (9.5% in the case 
of strain 1761; 0.9% in the case of strain 1216), compared to the invasion efficiency of 
the positive control FSL F8-146.   
 Mutation type 11 was found in food isolates 747 and 1305, serotypes 1/2b and 
1/2c, respectively. Rousseaux et al. [56] and Ragon et al. [49] had described the same 
mutation  leading to a 685 aa. InlA  in food isolates from France, belonging to serotype 
1/2c, the same as isolate 1305, but we also found this mutation type in a 1/2b isolate 
(747). As predicted, these two food isolates showed reduced invasion efficiency in 
Caco-2 cells, with values 65.2% and 1.4% for 747 and 1305. Van Stelten et al. [64] 
noted that inlA PMSC mutations, except type 6 and 12, occur almost exclusively in 
isolates from countries where these  mutations were originally described. However, in 
the present study it was found that mutation type 11, originally described from France, 
was also identified in two different food isolates from Portugal. So mutation type 11 is 
not exclusive from French isolates.   
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 Food isolate 842 also showed a PMSC mutation in inlA leading to a truncated 
form of InlA and the evaluation of ability to invade Caco-2 cells demonstrated a 
reduced invasion efficiency (1.4%); both results are concordant, an isolate with PMSC 
leading to a truncated form of InlA shows attenuated invasion efficiency in Caco-2 cells. 
This mutation type (12) was the first mutation in inlA leading to a PMSC described in 
1998 by Jonquières et al. [28] in France and, after that, was described also in France 
[49], in Portugal [15] and in USA [63, 64] in food and clinical isolates belonging to 1/2c 
and 3c serotypes. 
  These results confirm that isolates with PMSC mutations in inlA, which are 
predicted to lead to a truncated InlA, show attenuated invasiveness in Caco-2 cells. 
The three mutation types found, encode a truncated form of InlA with no cell wall 
anchor and, this way, L. monocytogenes is unable to adhere to the host cell by E-
cadherin – InlA interaction. The reduced invasion phenotypes can be explained by 
three different mechanisms: (i) PMSC mutations in inlA leading to a truncated and 
dysfunctional InlA necessary for internalization of L. monocytogenes in human host 
cells, as demonstrated in Caco-2 cell line [34], (ii) reduced inlA transcript levels [54], 
and, (iii) reduced motility of L. monocytogenes [54]. Mechanisms (ii) and (iii) may 
explain the invasion efficiency results below FSL F8-146 invasion efficiency of 1547, 
2103 and 1001 clinical isolates and 1044, 994/1, 930/1 and 925/3 food isolates, which 
do not show PMSC in inlA, analyzed by sequencing. Future studies will be necessary 
to understand the association between the three mechanisms to explain attenuated 
virulence of some food and clinical isolates.   
 PMSC mutations in inlA have been described as a common event in food isolates 
and a rare event in clinical isolates [64]; Jacquet et al. [26] demonstrated that 96% of 
the clinical strains have full-length InlA whereas only 65% of food strains show the full 
length protein. In this study we found PMSC in four food isolates and in one clinical 
isolate (1761) from a CSF catheter, belonging to lineage II (serotype 1/2a).  
 Epidemiologically, DNA sequencing of inlA and virulence phenotype studies show 
that, through consumption of contaminated foods, humans are frequently exposed to 
virulence-attenuated L. monocytogenes isolates carrying PMSC mutations in inlA. 
Because of heterogeneity in virulence among L. monocytogenes and the susceptibility 
of the host, an infectious dose is not defined. However it is known that ID50s (dose 
required for systemic infection in 50% of the subjects) in guinea pigs is lower for an 
epidemic clone strain than for a isolate carrying a PMSC mutation in inlA [8]. 
Nightingale et al. [40] reported that oral exposure to L. monocytogenes with PMSC in 
inlA provides protection to subsequent exposure to virulent strains.  
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 Listeria monocytogenes serotypes from isolates carrying PMSC in inlA, in this 
study, are 1/2b, belonging to lineage I, and 1/2a and 1/2c belonging to lineage II. 
Lineage I is over-represented among human cases and are associated with listeriosis 
outbreaks in USA and with sporadic cases in Northern Europe [45], in particular with 
serotype 4b. While lineage II are over-represented in food isolates [41, 57] and more 
than 30% show attenuated-invasion efficiency in Caco-2 cell line due to PMSC in inlA 
[45].  
 Listeriosis outbreaks are usually associated with milk and dairy products such as 
cheese and butter, and to RTE products [68]. In fact, the Portuguese outbreak isolate 
2652 is from goat and cow fresh cheese and it belongs to lineage I (serotype 4b), over-
represented in listeriosis outbreaks and it shows inlA leading to a full-length InlA, 
necessary to cause infection.  
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5 Conclusion 
 
 Listeria monocytogenes is a food-borne pathogen exhibiting considerable 
diversity in virulence-associated phenotypes dependent on serotypes and strain origin. 
 In this study it was possible to detect PMSCs in inlA, previous described, in food 
and clinical isolates from Portugal by inlA sequencing and characterize those isolates 
phenotypically through the efficiency of invasion in the Caco-2 cell line. In eleven food 
isolates, four of them (36.4%) display PMSCs in inlA, Only one clinical isolate (9.1%) 
shows PMSC, leading to a predicted InlA of 492 aa. So, PMSCs are prevalent in food 
isolates and under-represented among clinical isolates, despite the relatively low 
number of strains analyzed. Phenotypically, it was possible to relate the presence of 
PMSCs with invasion efficiencies below that of the positive control FSL F8-146. 
Isolates from the Portuguese outbreak reveal invasion efficiencies above 100% and do 
not show PMSCs in inlA, as expected.  
  InlA protein is necessary to cross the intestinal barrier, thus being a critical 
virulence factor to allow L. monocytogenes infection. When inlA shows PMSC leading 
to a truncated form of InlA, the isolate has a reduced invasion efficiency. It is necessary 
to understand the importance of attenuated-virulence strains with PMSC in inlA, mainly 
in foods, and how this could be explored to prevent risk of human disease. 
 Despite the important results obtained by Caco-2 invasion assays, it is necessary 
to study other in vitro and animal models to understand the pathophysiology of 
listeriosis in vivo.  
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